| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |